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Industrial meaning  
of university basic research  
in modern economies
1. Introduction
The meaning of scientific knowledge in creating innovation and improv-
ing economies’ growth potential is unquestioned. Universities play a vital role 
in national innovation systems, they are a source of both skilled labour and 
valuable scientific knowledge embodied in the R&D output. The role of basic 
research in modern economies seems to change. Previously, in the linear model 
of innovation, basic research has been the first stage of innovation process, fol-
lowed by the applied research and experimental development. Nowadays, basic 
research seem to be a sterling product itself, ready to achieve the full market 
value. Basic research, nowadays conducted mainly at universities have some 
important advantages. First of all, they are publicly funded, as a basic universi-
ties’ activity aimed at reducing the uncertainty of expanding the body of pure 
knowledge and creating potentially useful solutions. Secondly – thanks to the 
institutional change within modern universities, which is the emergence of the 
universities’ “third mission” , there appeared the possibility of selling the basic 
research output thanks to the commercializing procedures adopted widely by 
research universities. Those procedures enable shortening the distance form 
the pure science to market-valuable solution.
The goal of the article is to show the changes in the approach to the univer-
sity basic research as a part of the innovation process.
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2. Innovation models
Nowadays, as economic systems evolve in the direction of knowledge-orient- 
ed ones, the knowledge (and especially the scientific knowledge) is a factor of 
great importance for the economic development. Post industrial economies, ac-
cording to Bell, differ from industrial ones, and the distinguishing factor is the 
attitude to the technological innovations. Formerly innovations resulted from 
business practice, nowadays they are the result of theoretical research [12]. 
According to Bell, the technological progress is dependent on the development 
of science . The development of technology is getting more and more similar 
to the scientific research because of the utilizing of typically scientific methods 
and research results. Naturally, knowledge has always been important for the 
economies, but post-industrial society is involved in research programs in order 
to broaden the theoretical knowledge which is useful in economies’ problems 
solving. Post-industrial economy needs both highly qualified employees and ad-
vanced scientific research. Universities became the main institutions in modern 
economies. Bell said [1]: “if an enterprise has been the main institution through 
the past 100 years, according to its role in organizing production and economies 
of scale, the university is supposed to be the most important institution through 
the next 100 years, because of the innovation and knowledge it creates. 
For decades after World War II the generally accepted model of innovation 
was the ‘linear model of innovation’. This model explicitly and implicitly domi-
nated much of the theoretical debates and science and technology policy for-
mulations. In the model, basic research produces theories and findings that are 
redefined in applied research, tested in development processes and after that 
commercialized as industrial innovations. Each level in the linear model produc-
es outputs that are transferred to the next level as inputs. The flow of knowledge 
is also unidirectional, i.e., later stages do not provide inputs for earlier stages[3]. 
This linear model of innovation and the idea of “public good “ character 
of science laid the basis for academic autonomy. The fact, that they are mostly 
funded with public funds caused their greater autonomy in shaping both the 
scientific problems to solve and the methods to be used in problem solving. As 
the innovations were seen resulting automatically from basic research, they be-
came a flagship activity of universities, which, from now on, got the autonomy of 
creation of the future. 
The great change in the innovation process took place in the period of de-
cade (mid 1970s – mid 1980s). In that time the attitude to the nature of knowl-
edge changed. Polanyi (1966) demonstrated first that any knowledge was a com-
bination of “tacit” and “explicit” dimensions [18]. The impact on fundamental 
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research was demonstrated by Collins (1974), and his findings were, that the 
nearer to the discovery the most difficult it is to take-up knowledge and make 
it circulate – only those, who participate in a project can fully understand its 
nature [4]. The implication was that in high technology sectors, it was important 
for firms to develop strong connections with academic labs if they wished to be 
in a position to master new knowledge. The notion of “absorptive capacity” [9] 
translated this new understanding of the circulation of knowledge. This explains 
the exponential growth observed from the beginning of the 1980s in so-called 
“industry-university collaborations” (or said more precisely in joint research proj-
ects between public and private research actors) [10]. 
Also the understanding of the innovation process changed. The idea of a lin-
ear model of innovation was found as the oversimplified one. As an alternative 
to the linear model, Kline and Rosenberg [9] (presented a model they called ‘the 
chain-linked model’). In this model, science exists alongside development pro-
cesses, as it is used in any stage of such process when needed. Furthermore, sci-
ence can be divided into two components: known, existing scientific knowledge 
and scientific research. If a problem is confronted in innovation, the existing 
knowledge is consulted first. Only if this consultation is not producing results, 
scientific research is needed. In this view, scientific research is not the initiating 
step, but a factor that is utilized at all the points in the innovation processes. 
Of course the chain linked model is not the only alternative here. The new-
est attitudes to the innovation process are network model of innovation or open 
innovation [16]. 
Innovation process – no matter what model we adopt, can be translated as 
a process of knowledge transformation – from purely scientific to practical one. 
Since the postwar period until now the most valuable type of knowledge is a sci-
entific knowledge. Thanks to this knowledge dimension scientists have a vital im-
pact on economies development direction. The institutions that are devoted to 
the research activity are universities. Universities also educate, and in some cases 
this is their dominant activity, but in case of research universities – their scientific, 
innovation-oriented output is the greatest value.
3. Scientific background of innovation
The role of science in creating the useful knowledge is unquestioned. On the 
theoretical background, the idea of science as a public good was forwarded by 
seminal analytical work by Nelson (1958) and Arrow (1962), who introduced the 
idea of ‘market failure’ in the behaviour of firms investing in scientific research [6].
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The traditional ‘market failure’ approach to the economics of publicly 
funded research centers on the important role of information in economic ac-
tivity. Drawing on the work of Arrow (1962), it underlines the informational 
properties of scientific knowledge, arguing that this knowledge is non-rival and 
non-excludable. Non-rival means that others can use the knowledge without 
detracting from the knowledge of the producers, and non-excludable means 
that other firms cannot be stopped from using the information. The main prod-
uct from government-funded research is thus seen to be economically useful 
information, freely available to all firms. By increasing the funds for basic re-
search, government can expand the pool of economically useful information. 
This information is also assumed to be durable and costless to use. Government 
funding overcomes the reluctance of firms to fund their own research (to a so-
cially optimal extent) because of their inability to appropriate all the benefits. 
With government funding, new economically useful information is created and 
the distribution of this information is enhanced through the tradition of public 
disclosure in science [20].
The idea of proprietary science appeared with the advent of the neolib-
eral era, which influenced modern, western economies[17]. The development 
of the neoliberal attitude to universities brought into the existence the aca-
demic capitalism, where the profitability became a key-word for many spheres 
of economy, also for universities. Universities started to take part in different 
business-like activities. This goes far beyond nonacademic consumption items 
(such as logos, tee shirts, etc.). Today, higher education institutions are seeking 
to generate revenue from their core educational, research and service func-
tions, ranging from the production of knowledge (such as research leading 
to patents) created by the faculty to the faculty’s curriculum and instruction 
(teaching materials that can be copyrighted and marketed) [19]. The idea of 
engagement between universities and society - the “third mission” of universi-
ties (after teaching and research), which puts them close to the society and 
industry, became a source of knowledge production and introduced changes to 
the innovation process.
4. The new dimension of scientific research
Scientific knowledge, e.g. knowledge created by scientists, usually at uni-
versities evolves. The academic science model, which has separated academic 
from industrial science and basic research from technological application does 
not any longer fit to the requirements of modern economies. Changes in the 
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model of knowledge creation entail a change in the approach to the ethos of 
science.
The academic science has been researched by Merton [14], who constructed 
four norms or “institutional imperatives” defining its ethos. These are universal-
ism, communism, disinterestedness, and organized skepticism. 
The great dimension in the attitude to the scientific knowledge is discover-
ing its market values. The possibility of using scientific research outputs as a com-
modity was possible thanks to emergence of knowledge transfer institutions, eg. 
intellectual property rights. Since that time one can easily say that knowledge 
creation has been replaced by the knowledge production.
The first important knowledge production model which can be found in the 
literature is the New Production of Knowledge [7]. The main proposition here is 
the emergence of a knowledge production system that is “socially distributed”. 
While knowledge production used to be located primarily at scientific institu-
tions (universities, government institutes and industrial research laboratories) 
and structured by scientific disciplines, its new locations, practices and principles 
are much more heterogeneous. To clarify this assertion the authors introduce 
a distinction between Mode 1 knowledge production, which has always existed, 
and Mode 2 knowledge production, a new mode that is emerging next to it and 
is becoming more and more dominant. The five main attributes of Mode 2 sum-
marize how it differs from Mode 1 (which can be a synonym of the academic 
science). 
Mode 2 knowledge is generated in a context of application. Of course, 
Mode 1 knowledge can also result in practical applications, but these are always 
separated from the actual knowledge production in space and time. This gap 
requires a so-called knowledge transfer. In Mode 2, such a distinction does not 
exist. A second characteristic of Mode 2 is transdisciplinarity, which refers to 
the mobilization of a range of theoretical perspectives and practical methodolo-
gies to solve problems [8]. Transdisciplinarity goes beyond interdisciplinarity 
in the sense that the interaction of scientific disciplines is much more dynamic. 
In addition, research results diffuse (to problem contexts and practitioners) 
already during the process of knowledge production. Thirdly, Mode 2 knowl-
edge is produced in a diverse variety of organizations, resulting in a very het-
erogeneous practice. The range of potential places for knowledge generation 
includes not only universities and colleges, but also research centers, govern-
ment agencies, industrial laboratories, think-tanks and consultancies. These 
sites are linked through networks of communication and research is conducted 
in mutual interaction. The fourth attribute is reflexivity. Compared to Mode 1, 
Mode 2 is based on an instant dialogue of knowledge-producing actors, and has 
the capacity to incorporate multiple views. 
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The more advanced concept of knowledge production is Ziman’s concept 
of post-academic science and its more orthodox variation: industrial science 
[22]. In Ziman’s notion of post-academic science, he incorporates elements 
from several other approaches. Ziman intends to describe and explain a set 
of developments in scientific knowledge production. To summarize, post-ac-
ademic science refers to a ”radical, irreversible, worldwide transformation in 
the way science is organized, managed and performed”[22]. Industrial science 
can be characterized by the following five (strongly connected) designations. 
First, science has become a collective activity: researchers share instruments 
and co-write articles. Moreover, both the practical and fundamental problems 
that scientists are concerned with are transdisciplinary in nature, calling for 
a collective effort. Second, the growth of scientific activities needs capital sup-
port. The resources available for research seem not to increase much more, 
creating a need for accountability and efficiency. Thirdly, but strongly related, 
there is a greater stress on the utility of knowledge being produced. Successful 
application of scientific knowledge in the creation of new products and prac-
tical solutions in certain types of business activity has caused “impatient ex-
pectations” of industry, government and the public. The expectancy refers to 
the scientific knowledge diffusion rate and its impact on the company’s profits 
and the state’s welfare. There is an increased pressure on scientists to deliver 
more expected and desired value that can provide long-term gains. Moreover 
policy-making in science and technology has intensified the competition for 
resources. In such a situation competing for a lucrative contract may diminish 
the significance of the researcher’s scientific credibility. Research teams can be 
conceived as small business enterprises, their staff as “technical consultants”. 
Finally, science has become “industrialized”: the links between academia and 
industry have become close and the relationship has a financial dimension. This 
phenomenon is in contradiction to the Mertonian norms of academic science. 
Due to the industrial orientation a new set of norms can be discerned, which 
Ziman labels as PLACE: 3URSULHWDU\/RFDO$XWKRULWDULDQ&RPPLVVLRQHGand 
([SHUW. 
The concept of post-academic science is quite similar to that of Mode 2 
knowledge production. While New Production of Knowledge explicitly states 
that Mode 2 emerges “next to” Mode 1 research (which means that academic 
science still exists) and suggests a future in which both develop in co-evolu-
tion.
As the short literature review shows, the change in the attitude to knowl-
edge creation is evolving, and the direction of this evolution is to treat knowl-
edge as a commodity. Universities as the sources scientific knowledge and 
of course well-educated scientific personnel are the significant chain of the 
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knowledge creation. But using its potential in purpose of creating innovations 
faces several problems. First of all the problem of transmitting the results of 
scientific research into the market. This matter concerns mainly the process 
of commercialization, e.g. the subject of commercialization, the IPRs and com-
mercialization process organization. Besides the industry is willing to achieve 
valuable knowledge from universities (embodied in the outcomes of university 
research and development (R&D) activity). The problem of knowledge com-
mercialization affects the science- industry relations and results in different 
forms of fruitful cooperation.
5. Basic research in use – new growth areas
Basic research may be considered as the first step in the knowledge genera-
tion or in the innovation process. Since the basic research is conduced mainly 
at publicly funded universities, nowadays the new phenomena in knowledge 
creation (Mode 2 or industrial science described in previous sections) can be 
easily adopted. It is worth to underline here that basic research financed pub-
licly can be attractive especially for new-potentially profitable science areas. 
Indubitably, the growth of economies in industrialized countries has been driv-
en mainly by the pursuit of scientific research, the implementation of innovative 
engineering solutions and a constant flow of technological innovation. Basic re-
search is basically conduced at the universities and public research institutions. 
Its role is mainly to advance the knowledge and scientific discoveries. Scientists 
often endeavor to solve purely scholar problems, where there are no direct 
expectations (or even interest) to utility implication. As a consequence of such 
an activity basic research may produce results of vast scientific value, but not 
necessarily with plausible economic significance [11]. It is worth to underline 
here, that the increased importance of basic research is strictly connected with 
the emergence of new technologies and knowledge, that have the ability to 
change the direction or accelerate the economies development. The scientific 
fields of such an importance undoubtedly are information technology, health 
innovations (like biotechnology), energy-saving and environmental innovation. 
They depend on and require very basic research that might eventually material-
ize to marketable assets. 
After information technology, biotechnology is increasingly recognized 
as the next wave in the knowledge-based economy. A recent estimate of the 
European Commission suggests that by the end of the decade the global bio-
technology market could amount to over 2,000 billion Euro. Despite the capital 
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intensity of the industry, the growth rate of the biotechnology industry during 
the 1990s, and to a lesser extent, the beginning of the 21st century has been 
impressive. Biotechnology has been at the core of a number of important de-
velopments in the pharmaceutical, agrochemical, energy and environmental 
sectors. In particular, progress in the field of molecular biology, biotechnology 
and molecular medicine has highlighted the potential of biotechnology for the 
pharmaceutical industry [2]. 
The literature shows there is a dispute on the importance to drug discov-
ery of basic research conducted at Public Sector Research Institutions. Zycher 
et al [21] found that at least 80% of 35 major drugs were based on scientific 
discoveries made by public institutions. Toole found a quantifiable correlation 
between investment in publicly funded basic research and corporately funded 
applied research: 1% increase in the funding in public basic research led to 
increase of 1,8% in the number of successful applications for new molecular 
entities in the lag of 17 years. The research conducted by Zycher et al shows 
also that, public research institutions have contributed to the discovery of 9,3% 
to 21,2% of all drugs involved in new-drugs applications approved during the 
period from 1990–2007. These proportions are higher than those identified 
before [21]. The examined data also suggest that public research institutions 
in USA tend to discover drugs that are expected to have a disproportionately 
important clinical effect.
The strong growth of the biotechnology industry in the recent years has 
been mirrored by the stronger than average growth rate for patent applications 
and patent grants that relate to biotechnology inventions. According to the OECD 
data, a number of patents granted in biotechnology rose 15% a year at the USPTO 
during the period 1990–2000, and 10,5% at the EPO (it is worth to notice, that 
the overall increase in patents reached 5% in the requested period). Patenting 
and licensing from universities and public research centers are a particularly im-
portant phenomena in health-sciences. in the USA licensing revenues reached 
1.6 billion $ in 2005 [15].
It should be noted here, that patent is very often just a beginning of a very 
costly process of developing a marketable commodity [12]. The biotechnology 
industry exemplifies this problem. It is a common knowledge that the develop-
ment of medical innovations (and especially new drugs) requires massive long-
term investments in R&D, expertise in pharmaceuticals development, obtaining 
regulatory approval, production and marketing capacities [12]. On average – de-
veloping a new drug takes about 12 years. A recent estimate of the average cost 
of developing an innovative new drug is over $800 million, including expendi-
tures on failed projects and the value of forgone alternative investments. That 
is probably why pharmaceutical companies find viable innovation to be much 
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more accomplish internally – within firm’s capacities. The challenges encourage 
large pharmaceutical firms to pursue collaborative alliances. As the Table 1 shows 
majority of these alliances materialize through licensing transactions with univer-
sity scientists, which is the pure industrial science example. The publicly funded 
academic research serves both the industry and the society. 
Table 1 
List of patented new drugs from universities in Israel
Product Indication Licensee Sales in 2011 
(in milions)
Licensor
Copaxone Multiple Sclerosis Teva $ 3,570 Weizmann Institute
Rebif Multiple Sclerosis Merck-Serono Eur 1,691 Weizmann Institute
Exelon Alzheimer Novartis $1,067 Hebrew University
Doxil/Caelyx Cancer Scheering- 
-Plough
$ 320 Hebrew University and 
Hadassah Hospital
Aziltec Parkinson Teva $290 Technion Medical Scholl
Erbitux Cancer Merck-Serono EUR 855 Weizmann Institut
Source: [12]
The data presented in the chapter 5 show that there is a great correlation 
between university R&D in the field of biotechnology and biotechnology devel-
opment. Moreover, one can easily see that universities tend to attract biotechno-
logical companies as competent research partners. Thanks to the development 
of economic institutions enabling knowledge transfer form public universities to 
private corporations, the scientific output originating at universities can achieve 
marketable properties and be the source of income.
The changes in the attitude to the role of academic science in modern econo-
mies can be easily noticed on examples of new, innovative, economic growth gen-
erating areas of industry. Chemical industry, information technology, life sciences 
– all those industry branches derive from the university laboratory. Consequent 
shortening of the distance between science and industry causes the change both 
in the shape of modern scientific research and the innovation process. The aca-
demic R&D is nowadays more the output of industrial science than of academic 
one. Proprietary, local, authoritary, commissioned and expert are adjectives de-
scribing the attributes of modern scientific research model. 
Research conducted at universities has also a great advantage in comparison 
to the corporate ones. It is financed by the state. The issue of knowledge com-
mercialization still causes heated controversies among scientists, managers and 
technology transfer practitioners. Violation of the rules of open, public science, 
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especially in the field of life sciences, can be harmful especially for the cumulative 
innovations and for developing countries [20]. The basic economic justification 
for university patenting is based on the idea that it facilitates the commercializa-
tion of the discoveries produced by scientific research. Thanks to well defined 
IPRs, firms or individuals have the incentives to invest additional R&D in product 
development because imitation is deterred and they can appropriate the related 
monopoly rents. Without a patent, the non-rival and non-excludable nature of 
knowledge would dissipate the expected profits and, therefore, the incentives to 
have extra R&D to bring such a product into the market [15]. 
The possibility of using publicly funded research for private (corporate) 
purposes gives rise to a new phenomena. The idea of industrial science which 
caused more direct and close relations between scientists and businessmen pri-
marily could be understood as a trial of privatizing scientists instead of their 
scientific research output. The industrial science attitude often meant that those 
were people – scientists who took up work at huge laboratories financed by large 
corporations, loosing scientific independence but gaining good work conditions 
and money. The commercialization process affected more people and their pe-
culiarities (like the tacit dimension of knowledge they are part of) than research 
results they were authors of.
Modern economies’ economic policy puts an emphasis on the knowledge-di-
rected development and growth. It means that a lot of public money is addressed 
to research institutions in order to provoke better economic performance. In the 
years of economic crisis corporations, which in the years of economic growth 
spent a lot of money on R&D activity, do savings using the possibility of market 
interplay with public research institutions like universities. And the biotech- and, 
in a wider prospect, health-sciences as the flagships of the economic- and social- 
quality change scientific disciplines, do realize such a crisis scenario.
In-licensing is understood as the licences bought by pharmaceutical indus-
try from universities and public R&D laboratories. Out-licensing means licenses 
sold by pharmaceutical corporations to other entities. As the Figure 1 shows, the 
number of licenses bought from the universities grows in the two consecutive 
years with the stable number of licenses sold by the pharmaceutical corporations 
to other entities. 
As the Figure 1 shows, pharmaceutical companies limit their research activity 
and in return they concentrate on buying licenses from public research entities 
like universities etc. The example of Sanosfi-Aventis shows that this company 
switched to the external sources of R&D. The numbers representative for this 
company prove that the internal R&D practically does not exist (minimal focus 
on out-licensing). The very similar data one can easily see on the example of 
Roche or Abbott, but with smaller engagement in in-licensing. 
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Figure 1. Licensing agreements in the pharmaceutical industry in 2008 and 2009,  
by the company name
Source: [5]
University basic research are nowadays the key point in fostering of develop-
ment of new, innovative industries. Publicly funded university research became 
the very important part of the innovation process in pharmaceutical industry. 
Undoubtedly those are symptoms of the reversed trend in the knowledge privati-
zation. As described above, primarily scientific research outputs privatization was 
associated with the personal dimension of knowledge – scientists. Nowadays the 
situation looks diverse – scientists sell their research output using the university 
technology transfer channels, but do not lose their relationship with the university. 
For the company university affiliation of a scientist is the guarantee of cost saving.
6. Conclusions
University basic research are the research of key importance for innovative 
industries. Primarily presumed as the first part of the innovation process, nowa-
days constitute a quite new phenomenon on the innovation scene.
Thanks to the introduction of economic institutions like IPR’s the market ex-
change of basic research output is possible. It is a factor of a great importance be-
cause basic research conducted at the publicly funded universities are a source of 
public knowledge, which aim is enlarging the existing knowledge pool, not giving 
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private profits. Thanks to the IPRs one can say, that the academic science (or even 
post-academic one) changed to the industrial science. Industrial science primarily 
described the situation when scientists decided to loose their research autonomy 
in return of the great research conditions in corporations’ lab followed by satisfac-
tory salary. Nowadays one can easily notice, that in the matter of innovative in-
dustries like biotechnology, information technology etc. the process of knowledge 
privatizing is reversed. At present pharmaceutical companies more and more often 
look for savings outsourcing R&D to the university laboratories. It means, that uni-
versities do license the rights to inventions the university scientists are authors of. 
Scientists earn royalties. It means that the product – a research output is privatized, 
with no additional personal costs connected with scientists employment.
As the research show – new drugs are produced mainly thanks to univer-
sity basic research. Thanks to public funds and laboratories. It makes university 
research an attractive source of potentially useful innovation, and public funds 
devoted to them rise their attractiveness even more. 
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